PRESS RELEASE published on 04/30/2024 at 23:14, 2 years 1 month ago Annual financial and audit reports / Terms of availability of the annual financial report Valerio Therapeutics reports full year 2023 financial results and provides clinical development updates. The company's cash position is €6.8 million as of December 31, 2023, ensuring financial visibility until Q4 2024 Financial Results Cash Position 2023 Clinical Development Valerio Therapeutics
Published on 06/29/2026 at 09:01, 19 minutes ago HM Exploration Discovers New Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 06/27/2026 at 16:50, 1 day 16 hours ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 2 days 7 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 2 days 9 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 2 days 10 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/29/2026 at 09:00, 20 minutes ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY
Published on 06/29/2026 at 09:00, 20 minutes ago Removal- The Master and Fellows of the College of the Great Hall of the University, commonly called University College in the University of Oxford
Published on 06/29/2026 at 09:00, 20 minutes ago Andera Partners joins the European Life Sciences Coalition (ELSC) with the aim to support the mobilization of capital for life sciences innovation in Europe
